BE HEARD I and BE HEARD II are the first Phase 3 trials to evaluate the efficacy and safety of an IL-17A and IL–17F inhibitor, BIMZELX ® (bimekizumab-bkzx), in the treatment ...
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa ...
—Identifying PROMIS domains that are most important to individuals with chronic skin disease can allow physicians to select those domains most relevant to their patients. A PROMIS profile not ...
—Researchers based at the University of Texas (UT) Southwestern Medical Center explored the possible misdiagnosis of HS flares as infections leading to hospitalization, unnecessary treatment ...
Boil-like swellings are the hallmark of hidradenitis suppurativa (HS), a chronic, recurrent inflammatory skin disease of the hair follicle. Painful, inflamed nodules are connected via sinus tracts ...
Based on his experience caring for patients with hidradenitis suppurativa (HS), dermatologist Christopher Sayed, MD, said that an exhaustive battery of tests is usually not required to diagnose ...
A recent study applied machine learning to medical and pharmacy claims data to develop a model for predicting hidradenitis suppurativa (HS) diagnosis, highlighting the potential for improved ...
Leisa Prescott suffered 24 years of inflamed abscesses and nodules on her skin, but doctors didn't know why. The sores began to develop in her groin, she had to get an incision and drainage to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback